60 related articles for article (PubMed ID: 3589291)
21. The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women.
Huang A; Yaffe K; Vittinghoff E; Kuppermann M; Addis I; Hanes V; Quan J; Grady D
Am J Obstet Gynecol; 2008 Mar; 198(3):265.e1-7. PubMed ID: 18313446
[TBL] [Abstract][Full Text] [Related]
22. [Bioavailability of 17 beta-estradiol after transdermal administration--dependence on the patch system].
Schmolling J; Kusche J; van der Ven H; Schander K
Zentralbl Gynakol; 1998; 120(3):121-5. PubMed ID: 9556902
[TBL] [Abstract][Full Text] [Related]
23. Randomized comparison of lower and standard dosages of transdermal estradiol on serum estradiol levels and vaginal maturation index.
Rungruxsirivorn T; Panyakamlerd K; Trerattanachart S; Taechakraichana N
J Med Assoc Thai; 2006 Sep; 89(9):1362-7. PubMed ID: 17100370
[TBL] [Abstract][Full Text] [Related]
24. [Transdermal estrogen substitution in the postmenopause].
Fontana-Klaiber H; Koller J; Keller PJ
Gynakol Rundsch; 1987; 27(4):225-33. PubMed ID: 3436573
[No Abstract] [Full Text] [Related]
25. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
Hedrick RE; Ackerman RT; Koltun WD; Halvorsen MB; Lambrecht LJ
Menopause; 2009; 16(1):132-40. PubMed ID: 18971794
[TBL] [Abstract][Full Text] [Related]
26. [Continuous, low dosage estradiol administration with a vaginal ring: a placebo-controlled study].
Casper F; Petri E; Benninghoff B
Zentralbl Gynakol; 1998; 120(9):449-53. PubMed ID: 9796090
[TBL] [Abstract][Full Text] [Related]
27. [Effectiveness of transdermal administration of 17-beta-estradiol in the management of menopause].
Grio R; Piacentino R; Abbondanza M; Cirnigliaro C; Fusi D; Corsello FP; Arrichiello G; Canestrelli M; Marchino GL
Minerva Ginecol; 1992; 44(1-2):19-21. PubMed ID: 1508379
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
Lee BS; Kang BM; Yoon BK; Choi H; Park HM; Kim JG
Maturitas; 2007 Aug; 57(4):361-9. PubMed ID: 17467203
[TBL] [Abstract][Full Text] [Related]
29. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
[TBL] [Abstract][Full Text] [Related]
30. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
Limpaphayom KK; Bunyavejchevin S
J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
[TBL] [Abstract][Full Text] [Related]
31. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
[TBL] [Abstract][Full Text] [Related]
32. Patch up the menopause.
Lancet; 1988 Apr; 1(8590):861-2. PubMed ID: 2895367
[No Abstract] [Full Text] [Related]
33. [A new synthetic estrone derivative for the treatment of climacteric disorders].
Cyran W
Med Welt; 1979 Mar; 30(10):384-8. PubMed ID: 368495
[No Abstract] [Full Text] [Related]
34. [Final results in the management of the climacteric with a combination of estradiol and estrone sulfate].
Ruiz Moreno JA; Rubio Lotvin B; Bolio Arista R; de Larios NM
Ginecol Obstet Mex; 1976 Feb; 39(232):145-9. PubMed ID: 770243
[No Abstract] [Full Text] [Related]
35. Proceedings: The treatment of climacteric disorders with a combination of estradiol and testosterone--an outline of the pathogenesis of psychic symptoms in the climacterium.
Navrátil J; Nováková D; Pichner J
Act Nerv Super (Praha); 1975; 17(4):307-8. PubMed ID: 1221812
[No Abstract] [Full Text] [Related]
36. The use of hormone implants for climacteric symptoms.
Cardozo L; Gibb DM; Studd JW; Tuck SM; Thom MH; Cooper DJ
Am J Obstet Gynecol; 1984 Feb; 148(3):336-7. PubMed ID: 6695979
[No Abstract] [Full Text] [Related]
37. [Diseases in the climacteric, with poor or without any organic findings].
Breckwoldt M
Z Allgemeinmed; 1975 Nov; 51(31):1415-7. PubMed ID: 128206
[No Abstract] [Full Text] [Related]
38. Transdermal dosage forms.
Shaw JE
Methods Enzymol; 1985; 112():448-61. PubMed ID: 3930919
[No Abstract] [Full Text] [Related]
39. [Multicenter study of Klimonorm (R) by the Jenapharm firm for treating the climacteric syndrome].
Czekanowski R; Stelmachow J; Radowicki S; Cekański A; Florczak M; Chlabicz P
Ginekol Pol; 1995 Apr; 66(4):237-45. PubMed ID: 8529942
[TBL] [Abstract][Full Text] [Related]
40. [Pro and contra hormonal substitution in the climacteric].
Vesper B
Gynakol Rundsch; 1988; 28 Suppl 2():175-8. PubMed ID: 3234914
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
